Cancer Rates by Country: Highest and Lowest Rates Worldwide in 2026

Cancer Rates by Country: Highest and Lowest Rates Worldwide in 2026

Key takeaways

  • Australia has one of the highest cancer rates worldwide, with 461.3 new cases per 100,000 people in 2024.
  • Bhutan and Nepal report some of the lowest cancer rates, although limited screening and underreporting may affect these figures.
  • Global cancer cases are projected to increase by 67%, from 20.6 million in 2024 to 34.4 million annually by 2050.
  • Cancer rates vary due to multiple factors, including aging, lifestyle, environmental exposures, infections, and access to healthcare.
  • Around 37% of cancer cases are linked to preventable causes, highlighting the importance of vaccination, tobacco control, screening, and prevention policies.

Cancer rates by country vary significantly, with Australia reporting one of the highest cancer incidence rates worldwide, while Bhutan and Nepal are among the countries with the lowest reported rates. According to the International Agency for Research on Cancer (IARC), Australia recorded approximately 461.3 new cancer cases per 100,000 people in 2024, compared with 82.6 in Bhutan and 90.1 in Nepal. These figures are age-standardized, allowing more meaningful comparisons between countries with different population structures.

Globally, an estimated 20.6 million new cancer cases and 9.8 million cancer deaths were recorded in 2024, according to GLOBOCAN estimates published in July 2026 (Sung et al., 2026). However, countries with higher reported cancer rates do not necessarily have worse cancer outcomes. Differences in screening, early detection, lifestyle factors, environmental exposures, and healthcare access all influence national cancer statistics.

So, which countries have the highest and lowest cancer rates, and what explains these differences? This article examines global cancer incidence rankings, the factors driving disparities between countries, and how the worldwide cancer burden is expected to change by 2050.

Which Countries Have the Highest Cancer Rates?

Australia reports one of the world’s highest cancer incidence rates, with an estimated 461.3 new cases per 100,000 people in 2024. The latest GLOBOCAN estimates also identify high incidence rates across several high-income countries, particularly in Oceania, North America, and Northern Europe (Sung et al., 2026).

The following table presents verified 2024 estimates for selected countries, using the same GLOBOCAN methodology.

Cancer Rates by Country: Highest and Lowest Rates Worldwide in 2026

The differences are substantial. Australia’s recorded incidence rate is more than four times India’s, even after adjusting for age.

However, incidence alone does not provide a complete picture of cancer outcomes. Countries with higher diagnosis rates may also have more developed cancer screening programs, stronger cancer registries, and better access to treatment.

What Is Driving High Cancer Rates in These Countries?

Several factors contribute to the elevated cancer incidence reported in high-income countries.

Ultraviolet radiation exposure is particularly important in Australia and New Zealand, where skin cancer represents a substantial public health burden. Including non-melanoma skin cancers can considerably change a country’s position in international rankings.

In Australia, for example, GLOBOCAN 2022 estimated a rate of 462.5 cases per 100,000 when non-melanoma skin cancer was included, compared with 322.4 when it was excluded.

Lifestyle-related risk factors also contribute to cancer incidence. Tobacco use, alcohol consumption, excess body weight, and physical inactivity are associated with several major cancers, although their relative importance varies between countries.

Screening and diagnostic access influence how many cancers are identified. Countries with established mammography, colorectal cancer screening, and comprehensive cancer registration systems may record more cases than countries where diagnostic services are limited.

These factors should not be interpreted as evidence that any single exposure explains a country’s overall cancer ranking. National cancer rates reflect multiple interacting influences.

Which Countries Have the Lowest Cancer Rates?

Bhutan and Nepal are among the countries reporting relatively low age-standardized cancer incidence rates in GLOBOCAN 2024. Bhutan recorded approximately 82.6 new cases per 100,000 people, while Nepal recorded 90.1.

Other countries, particularly in parts of Africa and South Asia, also report substantially lower rates than Australia, the United States, and several European countries.

Cancer Rates by Country: Highest and Lowest Rates Worldwide in 2026

A lower reported cancer incidence rate does not necessarily mean that people in these countries have a lower lifetime risk of developing cancer.

Some differences may reflect genuine variation in cancer risk factors, including tobacco use, diet, reproductive patterns, infection prevalence, and environmental exposures.

Other differences may arise from limited cancer screening, restricted access to diagnostic services, and incomplete cancer registration.

Cancer cases that are never diagnosed or formally registered may not be fully represented in national estimates. Consequently, countries reporting fewer cases can still face significant challenges with late-stage diagnosis, treatment access, and cancer mortality.

How Are Cancer Rates Compared Between Countries?

Cancer incidence is commonly expressed as the number of new cancer cases diagnosed per 100,000 people during a specified period.

However, comparing countries using their total number of cases can be misleading because countries differ greatly in population size and age structure.

Age-Standardized Incidence Rates

An age-standardized incidence rate (ASR) adjusts for differences in population age distribution using a standard reference population.

This is particularly important because cancer becomes more common with increasing age.

Without age standardization, countries with older populations might appear to have higher cancer risk simply because a larger proportion of their residents are in age groups where cancer is more frequent.

Age-standardized rates make comparisons more meaningful, although they cannot eliminate differences in cancer detection, classification, and reporting quality.

Why Does the Inclusion of Skin Cancer Matter?

Cancer statistics may include or exclude non-melanoma skin cancers, particularly basal cell and squamous cell carcinomas.

These cancers are common in countries with substantial ultraviolet radiation exposure, but their registration varies internationally.

For this reason, rankings based on all cancers including non-melanoma skin cancer should not be directly compared with rankings that exclude these cancers.

A notable example comes from GLOBOCAN 2022: Australia ranked highest when non-melanoma skin cancer was included, whereas Denmark ranked highest when it was excluded.

All international comparisons should therefore identify the dataset year, cancer inclusion criteria, age-standardization method, and population examined.

Why Do Cancer Rates Vary by Country?

Cancer rates differ because of variations in population characteristics, environmental exposures, health behaviors, infections, and healthcare systems.

Population Aging and Cancer Risk

Cancer risk increases with age as genetic changes accumulate and cellular repair mechanisms become less effective.

Countries with older populations often experience a greater overall cancer burden. Although age-standardized rates adjust for differences in age structure, population aging continues to influence the total number of cancer cases and the demand for healthcare services.

Tobacco, Alcohol, and Obesity

Tobacco remains one of the most important preventable causes of cancer, particularly lung cancer.

Alcohol consumption is associated with cancers including those of the breast, liver, colorectum, and upper aerodigestive tract. Excess body weight is also linked to several malignancies, including colorectal, endometrial, and postmenopausal breast cancer.

The prevalence of these risk factors differs between countries and can contribute to variations in cancer incidence.

Cancer-Related Infections

Infections account for a substantial proportion of cancers in some regions.

Human papillomavirus (HPV) is responsible for most cervical cancers, while chronic hepatitis B and hepatitis C infections increase the risk of liver cancer. Helicobacter pylori infection is an important cause of gastric cancer.

Differences in vaccination coverage, infection prevalence, sanitation, and access to preventive healthcare affect the distribution of these cancers internationally.

Environmental and Occupational Exposure

Environmental factors such as air pollution, ultraviolet radiation, and occupational exposure to carcinogens also influence cancer risk.

Exposure patterns differ depending on geography, industrial activity, environmental regulation, and working conditions.

For example, ultraviolet radiation contributes significantly to skin cancer risk in Australia, while prolonged exposure to certain occupational carcinogens can increase the risk of lung cancer and other malignancies.

Differences in Cancer Detection and Reporting

Some countries identify more cancers because screening and diagnostic services are widely available.

Others may report lower incidence because cancers remain undiagnosed or because population-based cancer registries lack complete national coverage.

These differences make it essential to distinguish between true variation in cancer occurrence and variation in the number of cancers detected and recorded.

How Do Screening and Early Detection Affect Cancer Statistics?

Cancer screening can increase the number of diagnosed cases, particularly when previously undetected cancers are identified. This does not necessarily indicate an increase in the underlying occurrence of disease.

Mammography can identify breast cancers before symptoms develop, while colorectal screening may detect cancer at an earlier stage and identify precancerous lesions that can be removed.

Cervical screening can detect precancerous abnormalities, allowing treatment before invasive cancer develops.

The impact of screening depends on the cancer type, the test used, program quality, population coverage, and access to follow-up care.

Screening can also identify some cancers that would never have caused symptoms during a person’s lifetime, a phenomenon known as overdiagnosis.

This is particularly relevant when interpreting differences in prostate and thyroid cancer incidence across countries.

Early diagnosis can improve treatment outcomes for several cancers, but increases in five-year survival statistics may partly reflect earlier detection rather than a true reduction in mortality.

For this reason, cancer incidence, stage at diagnosis, mortality, and survival should be evaluated together.

Cancer Rates by Country: Highest and Lowest Rates Worldwide in 2026

Are Global Cancer Cases Expected to Increase by 2050?

The annual number of new cancer cases worldwide is projected to reach approximately 34.4 million by 2050, a 67% increase from 2024, according to the latest GLOBOCAN estimates (Sung et al., 2026).

The increase is expected to be driven largely by population growth and aging, with the greatest proportional increases in countries with lower levels of human development.

Cancer Rates by Country: Highest and Lowest Rates Worldwide in 2026

These projections describe the expected increase in the absolute number of new cancer cases, not a 67% increase in age-standardized incidence rates.

This distinction matters because the number of cancer cases can rise even when the age-specific risk of developing cancer remains relatively stable.

As populations grow and a larger proportion of people reach older ages, healthcare systems will need greater capacity for cancer diagnosis, surgery, radiotherapy, systemic treatment, and supportive care.

The projected burden also highlights the importance of long-term investment in cancer prevention and early detection.

How Can Countries Reduce Cancer Rates?

Reducing cancer incidence requires a combination of prevention strategies, public health policies, and improved healthcare access.

A 2026 analysis by the World Health Organization (WHO) and IARC estimated that 37% of new cancer cases worldwide in 2022, approximately 7.1 million cases, were attributable to preventable causes (Fink et al., 2026).

Tobacco was the leading preventable contributor, accounting for approximately 15% of new cancer cases, followed by cancer-causing infections at 10% and alcohol at 3%.

Tobacco Control

Reducing tobacco exposure remains a major opportunity for cancer prevention.

Policies such as tobacco taxation, smoke-free environments, advertising restrictions, and smoking cessation support can lower tobacco use and subsequently reduce the incidence of smoking-related cancers.

HPV and Hepatitis B Vaccination

Vaccination is an important component of cancer prevention.

HPV vaccination can substantially reduce the risk of HPV-related cancers, particularly cervical cancer. Australia’s national HPV vaccination and screening programs provide an important example of coordinated cervical cancer prevention.

Hepatitis B vaccination also reduces the risk of chronic hepatitis B infection and subsequent liver cancer. Taiwan’s universal hepatitis B vaccination program has demonstrated long-term reductions in childhood liver cancer.

Screening and Earlier Diagnosis

Organized screening programs can reduce mortality from selected cancers by detecting disease earlier, when treatment is more likely to be effective.

Some screening approaches, particularly cervical and colorectal cancer screening, can also prevent invasive cancers by identifying and treating precancerous lesions.

However, screening programs require quality assurance, appropriate follow-up, and access to treatment to achieve their intended benefits.

Improving Access to Cancer Care

Reducing cancer deaths also requires timely diagnosis and access to effective treatment.

Countries need adequately trained healthcare professionals, pathology services, imaging, surgery, radiotherapy, essential medicines, and supportive care.

National cancer registries are equally important for monitoring disease patterns and evaluating prevention programs.

Reducing cancer incidence and reducing cancer mortality are related but different goals. Prevention primarily aims to stop cancers from developing, while early diagnosis and effective treatment can improve survival after cancer occurs.

What Are the Most Common Types of Cancer Worldwide?

Lung cancer was the most commonly diagnosed cancer worldwide in 2024, followed by female breast cancer, colorectal cancer, prostate cancer, and stomach cancer.

According to the latest IARC estimates, lung cancer accounted for approximately 2.6 million new cases, representing 12.8% of all newly diagnosed cancers (Sung et al., 2026).

Female breast cancer represented approximately 11.8% of new cases, followed by colorectal cancer at 9.9%, prostate cancer at 7.5%, and stomach cancer at approximately 4.8%.

Lung cancer was also the leading cause of cancer-related death, accounting for approximately 1.9 million deaths worldwide in 2024.

The most common cancers vary considerably between countries because of differences in risk factors, infection patterns, screening practices, and population characteristics.

Conclusion

Cancer incidence varies widely between countries, reflecting differences in risk factors, healthcare systems, screening practices, and cancer reporting.

While Australia and several other high-income countries report some of the highest incidence rates, countries such as Bhutan and Nepal record substantially lower figures. These comparisons require careful interpretation, particularly where diagnostic access and cancer registry coverage differ.

The latest projections suggest that the global number of cancer cases will continue to increase in the coming decades, placing growing demands on healthcare systems.

Strengthening cancer prevention, improving early diagnosis, expanding treatment access, and developing reliable cancer registries remain essential to reducing the global cancer burden and narrowing inequalities in cancer outcomes.

FAQ

What are the most common types of cancer worldwide?

Breast, lung, colorectal (colon and rectum), and prostate cancers are the most common globally, with lung cancer being the leading cause of cancer death.

Why do cancer rates vary so much between countries?

Cancer rates differ due to variations in lifestyle, environmental exposures, healthcare infrastructure, genetics, and accuracy of cancer detection and reporting systems.

Which countries have the highest cancer incidence rates?

High human development index (HDI) countries like Australia, New Zealand, the United States, and several European nations report some of the highest cancer rates, often above 400 cases per 100,000 population.

Can cancer rates worsen in the coming years?

Yes, global cancer cases are projected to increase by about 77% by 2050, driven by aging populations, population growth, and increasing exposure to risk factors like tobacco, obesity, and pollution.

What are the main risk factors for cancer?

Tobacco use, high body mass index (obesity), alcohol consumption, poor diet, lack of physical activity, infections (e.g., HPV, hepatitis), and environmental pollutants are major contributors.

How much cancer can be prevented through lifestyle changes?

About 30-40% of cancers could potentially be prevented by quitting smoking, maintaining a healthy weight, eating a balanced diet, being active, and avoiding harmful alcohol use.

Why do some low-income countries report lower cancer rates?

Underreporting due to limited healthcare access, lack of cancer registries, late diagnosis, and cultural barriers often mask the true cancer burden in low-HDI countries.

What advances are helping improve cancer detection and treatment?

Precision oncology, immunotherapies, personalized cancer vaccines, and artificial intelligence for early detection are key emerging innovations improving cancer care worldwide.

How does the One Health approach contribute to cancer research?

By integrating human, animal, and environmental health research, One Health propels faster discovery of treatments through comparative oncology, particularly using canine cancer models.

What is being done globally to reduce cancer disparities?

Multisectoral strategies including tobacco control, vaccination programs (e.g., HPV), strengthened healthcare infrastructure, and international collaborations aim to improve prevention, diagnosis, and treatment.

Aharon Tsaturyan
Fact checked by Aharon Tsaturyan MD, Medical Writer
Amalya Sargsyan
Medically reviewed by Amalya Sargsyan MD, Medical Oncologist